I 1 LYS 10 -11.607 -11.423
I 2 GLU 12 -14.918 -14.583
I 3 GLY 19 -16.862 -17.107
I 4 TYR 18 -19.121 -18.992
I 5 LEU 28 -19.273 -20.277
I 6 VAL 21 -17.057 -17.510
I 7 ASP 13 -14.688 -14.494
I 8 LYS 8 -11.273 -10.896
I 9 ASN 1 -10.006 -8.970
I 10 THR 9 -12.049 -11.699
I 11 GLY 8 -13.572 -12.932
I 12 CYS 8 -16.325 -15.368
I 13 LYS 19 -18.578 -18.627
I 14 TYR 27 -19.633 -20.480
I 15 GLU 4 -20.150 -18.293
I 16 CYS 28 -21.185 -21.969
I 17 LEU 0 -18.117 -16.034
I 18 LYS 9 -17.161 -16.223
I 19 LEU 3 -18.191 -16.444
I 20 GLY 1 -16.414 -14.641
I 21 ASP 0 -15.779 -13.964
I 22 ASN 23 -16.918 -17.617
I 23 ASP 0 -15.431 -13.656
I 24 TYR 13 -17.549 -17.026
I 25 CYS 28 -20.343 -21.223
I 26 LEU 8 -17.134 -16.084
I 27 ARG 6 -14.831 -13.815
I 28 GLU 25 -16.932 -17.860
I 29 CYS 27 -17.977 -19.015
I 30 LYS 10 -13.784 -13.349
I 31 GLN 13 -12.740 -12.770
I 32 GLN 28 -13.146 -14.854
I 33 TYR 29 -12.690 -14.565
I 34 GLY 13 -9.720 -10.097
I 35 LYS 0 -7.720 -6.832
I 36 GLY 6 -8.128 -7.883
I 37 ALA 31 -13.624 -15.622
I 38 GLY 8 -15.479 -14.619
I 39 GLY 32 -19.198 -20.671
I 40 TYR 6 -20.130 -18.505
I 41 CYS 12 -21.580 -20.478
I 42 TYR 17 -20.374 -19.986
I 43 ALA 4 -19.874 -18.049
I 44 PHE 1 -21.198 -18.875
I 45 ALA 16 -21.478 -20.848
I 46 CYS 29 -22.067 -22.864
I 47 TRP 11 -20.553 -19.454
I 48 CYS 30 -19.017 -20.280
I 49 THR 11 -15.656 -15.120
I 50 HIS 16 -12.543 -12.941
I 51 LEU 24 -12.187 -13.545
I 52 TYR 8 -7.888 -7.901
I 53 GLU 0 -7.106 -6.289
I 54 GLN 0 -6.287 -5.564
I 55 ALA 26 -10.680 -12.441
I 56 ILE 13 -11.750 -11.894
I 57 VAL 24 -15.101 -16.125
I 58 TRP 21 -15.395 -16.040
I 59 PRO 6 -13.493 -12.632
I 60 LEU 15 -10.665 -11.164
I 61 PRO 1 -4.482 -4.081
I 62 ASN 0 -2.795 -2.473 <=B
I 63 LYS 13 -7.504 -8.136
I 64 ARG 2 -9.940 -9.027
I 65 CYS 14 -12.963 -13.083
I 66 SER 4 -8.888 -8.326

Identified 1 B-Cell epitope residues out of 66 total residues